Clinical trials
Recruiting Fibrosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
182 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 16 |
| 2023 | 21 |
| 2024 | 31 |
| 2025 | 47 |
| 2026 | 30 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 182 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 8 |
| Northern Jiangsu People's Hospital | 8 |
| Hospices Civils de Lyon | 6 |
| Massachusetts General Hospital | 5 |
| Chinese University of Hong Kong | 4 |
| Institute of Liver and Biliary Sciences, India | 4 |
| Mayo Clinic | 4 |
| GlaxoSmithKline | 3 |
| M.D. Anderson Cancer Center | 3 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibrosis | 182 |
| Liver Cirrhosis | 29 |
| Hypertension, Portal | 24 |
| Non-alcoholic Fatty Liver Disease | 24 |
| Carcinoma, Hepatocellular | 19 |
| Fatty Liver | 13 |
| Liver Diseases | 12 |
| Ascites | 10 |
| Hepatic Encephalopathy | 8 |
| Liver Neoplasms | 7 |
Trials
Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.
82 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.